Case Study Case Study
Perspectives

Case Studies

Customer Stories

Testimonials

ALM Media, LLC

Josh Gazes, Senior Vice President – Operations

British Gas

Jess Johnson, Head of Operational Excellence

Mosaic Insurance

Mitch Blaser, Co-CEO

Mosaic Insurance

Krishnan Ethirajan, COO

Oxford Nanopore Technologies

Jason Hendrey, Senior Director, Global Customer Services

WS Audiology (WSA)

Christof Steube, Director of Finance Excellence

Kiwi.com

Leonard McCullie, Director, Vendor Management

Kiwi.com

Petra Reiter, Vice President, Customer Services

Flight Centre

Aaron Fadelli, Business Leader

Healius Pathology

Alex Cook, Head of Finance Operations

Varo Bank

Breanna Rivers, Partner Performance Manager

Yorkshire Building Society Group (YBS)

Jessica Lockwood, Process Automation Manager

WS Audiology (WSA)

Sharang Patil, Director of Group Finance Excellence

Priya Madan Mohan, VP for Group Accounting & Controlling

United Airlines

Chris Kenny, VP and Controller

GFG Alliance

Phillip Irish, General Manager, Shared Services Delivery, Quality & Governance

Energy Australia

Steve Corden, Outsource Operations Leader

Delaware North

Christopher Lozipone, Senior Vice President and Global Business Services Head

Moneycorp

Nick Haslehurst, Chief Financial & Operating Officer

Prodigy Finance

Nico Barnard, Head of Operations

M&T Bank

Chris Tolomeo, Senior VP & Head of Banking Services

Minerals Technologies Inc. (MTI)

Khem Balkaran, CIO

Church's Chicken

Louis J. Profumo, CFO & EVP

This success story showcases how the analytics center of excellence delivery model improved the relevance and quality of scientific content for a global pharma intelligence provider.

As we know...

Pharma companies rely on high-quality, timely and actionable intelligence to drive strategic decision-making and unlock value at speed. Data-led insights are vital to core enterprise objectives, including navigating market complexities, adapting to evolving customer expectations and optimizing portfolio strategy.

This puts the onus on intelligence and research firms to provide pharma companies with calibrated and connected data to support the end goal of helping patients get access to life-saving therapies.

The challenge for the pharma research firm was...

Meeting its clients’ growing demand for comprehensive coverage, high-quality analysis and rapid turnaround. The firm lacked the specialized skills required to process complex and unstructured scientific information, derive insights and provide an up-to-date view of the global drug pipeline and sales forecasts.

Compounding the challenge was the pressure to scale operations as the clients’ needs grew with geographic and portfolio expansions. With a lean team possessing generic skills, the firm found it difficult to manage existing content, let alone add new datasets or increase coverage.

WNS stepped in as a research and analytics partner...

Leveraging WNS Analytics Center of Excellence (CoE), a key pillar of WNS Analytics (our data, analytics and AI practice). We implemented a data management and analysis solution that involved deploying highly specialized domain experts, leveraging best practices in operations delivery, and incorporating Artificial Intelligence (AI) tools specific to the pharma and life sciences sector.

Key aspects of the solution included:

  • Employing highly sophisticated tools to acquire unstructured scientific information from public sources, third-party sources, syndicated reports and clinical trial registries of multiple countries
  • Deploying domain experts to identify and monitor drug-specific competitive information, resulting in the creation of therapy records
  • Integrating equity research into therapy records to publish a global view of the healthcare market
  • Developing an authoring tool to record, publish and report this highly strategic content from across the depth and breadth of global coverage

Streamlined operations enabled the pharma research firm to…

Retain and grow its customer base while expanding its global coverage of insights across the pharma, biotech and MedTech sectors. By steering end-to-end content operations, WNS created transformative value for the client through the constant enrichment and addition of datasets and ideation on new revenue streams. Furthermore, transitioning content operations enabled the firm to focus on new product development.

Tangible benefits for the client included:

  • 100x increase in company coverage
  • 50x scale-up in database coverage and geographic expansion
  • Less than 24-hour turnaround time on key projects

About WNS Analytics:

WNS is a digital-led business transformation and services company with 60,513 professionals across 64 delivery centers worldwide, including facilities in 13 countries. WNS combines deep industry knowledge with technology, analytics and process expertise to co-create innovative, digitally led transformational solutions with over 600 clients across various industries. WNS Analytics is the Data, Analytics and AI practice of WNS that enables business decision intelligence for clients by combining Artificial Intelligence (AI) and Human Intelligence (HI). We cater to 250+ global companies including Fortune 100 and Fortune Global 500 organizations. WNS Analytics is a robust practice of 6,500+ Domain, Data, Analytics and AI experts with proprietary AI-led assets and innovative technologies. We enable businesses to make transformative decisions backed by data-led intelligence, ensuring differentiated outcomes. WNS Analytics is an end-to-end Consulting-to-Implementation partner delivering business goals for clients with an integrated ecosystem of co-creation labs, strategic partnerships and outcomes-based engagement models

To know more, visit https://www.wns.com/capabilities/analytics

Join the conversation